InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,172.58
(
-3.25%
)
US TECH 100
17,194.80
(
-4.21%
)
Dow Jones
38,660.61
(
-2.71%
)
Brent Oil
76.01
(
-1.45%
)
Bitcoin
52,170.59
(
-9.82%
)
Post# of 77519
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

brwtrpilot

Send PM Follow Ignore
Followers 78
Posts 3789
Boards Moderated 0
Alias Born 12/21/2008

brwtrpilot

Re: EZ2 post# 38117

Tuesday, 11/29/2011 3:17:47 AM

Tuesday, November 29, 2011 3:17:47 AM

Post# of 77519
http://ih.advfn.com/p.php?pid=nmona&article=50205520&symbol=MMRF
Now look at a prior PR,
MMRGlobal filed five patent applications to treat lymphoma. They include protection for anti-CD20 antibodies, methods of treating B-cell lymphomas using anti-CD20 antibodies, manufacturing methods for idiotype vaccines to treat B-cell pathologies, methods for treating B-cell malignancies with vaccines, and methods for using the vaccines as combinational therapies with chemotherapeutic agents. They’ve also been issued a patent for methods of treating B-cell mediated malignancies..

manufacturing methods for idiotype vaccines
Dig around that for a while. have fun...
Man I like this company more day by day...
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up